.svg){kind=small}
Jul-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Market Insights Snapshot
In July 2026, Karma Originals’ mix is concentrated in Pre-Roll at 50.68% share and Concentrates at 48.07% share, with Pre-Roll down 12.36% year over year and down 59.42% month over month, while Concentrates fell 21.23% year over year and 17.20% month over month. Flower remains a fringe contributor at 1.24% share with a 74.25% month-over-month drop and no year-over-year baseline, alongside a 14.62% year-over-year increase in average price to $16.66 that outpaces both Pre-Roll’s and Concentrates’ sales declines. The pattern implies a portfolio over-indexed to two categories that both contracted faster month over month than the overall brand’s 17.42% year-over-year decline, concentrating risk and pressuring rank at Pre-Roll rank 32 in Nevada.
The synchronous month-over-month pullback of 59.42% in Pre-Roll against 17.20% in Concentrates shifts immediate momentum away from the lead category despite its 50.68% share, while the 1.24% Flower share and 74.25% month-over-month decline limit diversification. Coupled with a 14.62% year-over-year average price increase and a Pre-Roll placement at rank 32 in Nevada, the mix signals a positioning challenge where price and reliance on Pre-Roll amplify volatility, suggesting the brand must either reweight toward more stable subsegments within Concentrates or create a recoverable Pre-Roll assortment to avoid further rank slippage.
Competitive Landscape
Karma Originals ranks #32 in Nevada Pre-Roll in July 2026, down 3 positions year over year from #29, and down 21 positions from April 2026 when it was #11, after having peaked at #7 in January 2026; meanwhile, Rove sits at #1 after rising from #4 year over year with 92.2% sales growth, and STIIIZY slipped from #1 to #2 alongside a 37.5% sales decline, indicating that Karma Originals’ slide from a top-10 peak to the low-30s reflects share being reallocated toward faster-rising leaders and that its current trajectory implies erosion in retailer visibility unless the brand reclaims mid-teen ranks.
Notable Products
Octane Runtz Rush Infused Pre-Roll (1.2g) posted the steepest movement in July 2026 with an -82.4% MoM drop to rank 8, while Mango Runtz Infused Pre-Roll (1.2g) also fell -48.7% to rank 6, indicating sharp pullbacks in Runtz-flavored pre-rolls compared with the rest of the list. At the top, Indica RSO Syringe (1g) slipped -15.3% yet held rank 1, and Sativa RSO Syringe (1g) declined -17.8% at rank 3, whereas CBG/CBN/THC 1:1:4 Calm RSO Syringe (1g) rose +25.8% at rank 5, suggesting concentrate buyers are reallocating within the RSO line rather than leaving the category. Four of the top ten are Pre-Roll SKUs, but the only MoM mover among them was negative, while the sole positive MoM change came from a Concentrates SKU with $9,772 in July 2026 sales, implying product momentum is consolidating around functional RSO formulations rather than flavor-driven pre-rolls.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
